Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinson... ( NEW YORK Oct. 1 /- Intra-Cellular The...)

Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinson's Disease

Date:10/1/2010

NEW YORK, Oct. 1 /PRNewswire/ -- Intra-Cellular Therapies, Inc. today announced results from studies demonstrating the anti-Parkinson and other beneficial effects of ITI-002 (IC200214), the Company's novel and selective phosphodiesterase type I (PDE1) inhibitor.

Intra-Cellular Therapies presented preclinical data at the 2nd World Parkinson Congress held in Glasgow, Scotland, demonstrating ITI-002 was effective in improving motor and non-motor behaviors relevant to the treatment of Parkinson's disease. In well-established pre-clinical models of PD, ITI-002 was shown to restore normal motor function when given in combination with L-DOPA; ITI-002 increased the effectiveness of a sub-threshold and a sub-maximal dose of L-DOPA when the compounds were co-administered in unilaterally 6-hydroxy dopamine-lesioned or reserpine-treated mice. This combination resulted in a full restoration of the affected limb use and a re-establishment of normal mobility. ITI-002 also reversed the akinesia and catalepsy induced by the dopamine receptor antagonist haloperidol. In other pre-clinical models, ITI-002 was shown to improve cognitive performance and to increase daytime wakefulness without causing psychomotor stimulation.

"We are pleased to have demonstrated the ability of ITI-002 to improve motor and non-motor behaviors in pre-clinical models relevant to Parkinson's disease. These data suggest ITI-002 may be useful in prolonging the effectiveness and lowering the doses of dopamine replacement therapies, thereby providing for full restoration of motor function without causing troubling side effects in patients with Parkinson's Disease," stated Sharon Mates, Chief Executive Officer of Intra-Cellular Therapies. "Since ITI-002 acts by enhancing intra-cellular dopamine signaling, ITI-002 also may be useful as a stand-alone treatment early in this disease when residual dopamine is still present. In addition, patients with Parkinson's disease often suffer co-mor
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
2. Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
3. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
4. Vital Therapies Expands SILVER Trial to Saudi Arabia
5. Prometheus and Tarrot Laboratories Collaborate to Identify Markers Associated With Response to Anti-TNF Therapies in Crohns Disease
6. PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies
7. US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
8. NeoStem to Receive $700,000 from the U.S. Armys Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds
9. New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting
10. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
11. 5th Annual Summit to Feature New Stem Cell Therapies

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Graphite Metallizing ... self-lubricating bushings mounted in stainless steel pillow blocks. ... of GRAPHALLOY with the application and installation versatility ... Pillow Blocks work exceptionally well when submerged ... hostile liquids such as acids, alkalies, hydrocarbons, black ...

(Date:5/23/2013)... May 23, 2013 PI’s new ... and provide 15 mm travel range with closed-loop ... small dimensions make these new positioners the ideal ... A vacuum rated version is also available. ... and datasheets can be found at: , ...

(Date:5/23/2013)... On April 19th the Center ... search for the growing antibiotic resistant bacteria that may ... year long study were released late last month showing ... over previous years. For those suffering from bacteria driven ... resistant bacteria in food, may eventually help breed acne ...

(Date:5/23/2013)... 2013 Verenium Corporation (Nasdaq: VRNM ), ... and commercialization of high-performance enzymes, today announced that ... present at two upcoming conferences. (Logo: ... the Second Annual Marcum LLP Microcap Conference on Thursday, ... New York City. The presentation is scheduled to begin ...

Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2 Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3 Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 Verenium To Present At Two Upcoming Conferences 2 Verenium To Present At Two Upcoming Conferences 3

[0] Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications [0] Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] Verenium To Present At Two Upcoming Conferences

... N.J., July 21 BioNeutral Group, Inc. ("BioNeutral") (OTC ... Science Company announced today that at ATS Labs using ... Antimicrobial passed the difficult Quantitative Disk Carrier test ... difficile (C.diff) present in this test ...

... , , PALO ALTO, Calif., July 21, ... third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time ... of its investor conference call to review those quarterly results is scheduled ... , That live webcast can be accessed from Varian, ...

... , , KENILWORTH, N.J., July 21 ... for the 2009 second quarter. , , ... given us the strength to again power through tough challenges - delivering ... Fred Hassan, chairman and CEO. , , ...

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results Schering-Plough Reports Financial Results for 2009 Second Quarter

(Date:5/22/2013)... National Lung Screening Trial (NLST) investigators also conclude ... mortality with low-dose computed tomography (LDCT) versus chest ... primary paper is achievable at experienced screening centers ... more information to share with their patients about ... screening following today,s publication in the New ...

(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...

(Date:5/22/2013)... Legionella pneumophila bacteria is responsible for legionellosis, an ... to infect us, this pathogen has developed a complex ... in our cells, thus avoiding these acting against the ... research centre, CIC bioGUNE, in which teams from the ... the National Supercomputation Centre in Barcelona (BSC) have also ...

Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2 NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3 Fish oil may help the heart beat mental stress 2 Mechanism discovered which aids Legionella to camouflage itself in the organism 2

[0] NLST: CT detects twice as many lung cancers as X-ray at initial screening exam [1] Fish oil may help the heart beat mental stress [0] Mechanism discovered which aids Legionella to camouflage itself in the organism

... This press release is available in French ... kind, combines two complementary analytical brain imaging techniques, to provide ... the autistic brain. The study, published in the April issue ... by researchers at The Montreal Neurological Institute and Hospital ...

... It,s illegal for health products with medical formulations to be ... on animals ― a situation that has serious ethical and ... by Prof. Amit Gefen of Tel Aviv University,s Faculty of ... be needed for the necessary experimental trials. Dr. Gefen,s ...

... The six sponsoring societies for the meeting ... The American Physiological Society, American Society for Biochemistry ... American Society for Nutrition, and American Society for ... some of the science being presented April 24-28, ...

Cached Biology News:Dual approach gives a more accurate picture of the autistic brain 2 Dual approach gives a more accurate picture of the autistic brain 3 A lab rat -- created in the lab 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 2 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 3 Selected highlights of the research being presented at the Experimental Biology 2010 meeting 4

Dual approach gives a more accurate picture of the autistic brain A lab rat -- created in the lab Selected highlights of the research being presented at the Experimental Biology 2010 meeting

This antibody detects cdc42 on SDS-PAGE immunoblots....

Goat polyclonal to Nebraska Calf Diarrhea Virus (FITC) ( Abpromise for all tested applications). Antigen: Bovine (Nebraska Calf Diarrhea Virus)....

DNA fragmentation factor & Inhibitor of CAD...

Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...

Biology Products:

Rabbit Anti-cdc42 / Rac Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents Goat Anti-Human Nebraska Calf Diarrhea Virus Polyclonal Antibody, FITC Conjugated from Abcam Anti-Human DFF45 / ICAD (NT) Polyclonal Antibody, Unconjugated from Cell Sciences Rabbit Anti-Methionine Aminopeptidase 2 Polyclonal Antibody, Unconjugated from Abcam